7Nucleo E,Steffanoni L,Fugazza G,et al.Growth in glucosebased medium and exposure to subinhibitory concentrations of imipenem induce biofilm formation in a multidrug-resistant clinical isolate of Acinetobacter baumannii[J].BMC Microbiol,2009,9 (2):270-283.
3Wyllie D, Paul J, Crook D. Waves of trouble: MRSA strain dy- namics and assessment of the impact of infection control[ J]. J An- timicrob Chemother, 2011,66 ( 12 ) :2685-2688.
4Kulinska A, Czeredys M, Hayes F, et al. Genomic and functional characterization of the modular broad-host-range RA3 plasmid, the archetype of the lncU group[ J]. Appl Environ Microbial, 2008, 74(13) :4119-4132.
5Doi Y, Adams JM, amane K, et al. identification of 16S rRNA methylase-producing Acinetobacter baumannii clinical strains in North America [ J ]. Antimicrob Agents Chemother, 2007,51 ( 11 ) :4209-4210.
6Mugnier PD, Poirel L, Nordmann P. Functional analysis of inser- tion sequence ISAbal, responsible for genomic plasticity of Acine- tobacter baumannii[ J]. J Bacteriol, 2009,191 (7) :2414-2418.
8/rlo CM, Li CY, I-Io MW, et al. High rate of qacA- and qacB-posi- tire methicillin-resistant Staphylococcus aureus isolates from chlo- rhexidine-impregnated catheter-related bloodstream infections [ J ]. Antimicrob Agents Chemother, 2012,56( 11 ) :5693-5697.
10Adams-Haduch JM, Paterson DL, Sidjabat HE, et al. Genetic ba- sis of multidrug resistance in Acinetohacter baumannii clinical iso- lates at a tertiary medical center in Pennsylvania[ J]. Antimicrob Agents Chemother, 2008,52( 11 ) :3837-3843.